Hemoadsorption removes tumor necrosis factor, interleukin-6, and interleukin-10, reduces nuclear factor-κB DNA binding, and improves short-term survival in lethal endotoxemia*-Reference-Cited by-同舟云学术

Hemoadsorption removes tumor necrosis factor, interleukin-6, and interleukin-10, reduces nuclear factor-κB DNA binding, and improves short-term survival in lethal endotoxemia*

Published:2004-03 Issue:3 Volume:32 Page:801-805
ISSN:0090-3493
Container-title:Critical Care Medicine
language:en
Short-container-title:Critical Care Medicine

Author:

Kellum John A.,Song Mingchen,Venkataraman Ramesh

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Critical Care and Intensive Care Medicine

Reference21 articles.

1. The sirens' songs of confirmatory sepsis trials

2. Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis

3. Effect of Treatment With Low Doses of Hydrocortisone and Fludrocortisone on Mortality in Patients With Septic Shock

Cited by 167 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic mastocytosis successfully managed using CytoSorb® during cardiopulmonary bypass for aortic valve replacement;Annals of Cardiac Anaesthesia;2024-08-28

2. Hemoadsorption therapy for myoglobin removal in rhabdomyolysis: consensus of the hemoadsorption in rhabdomyolysis task force;BMC Nephrology;2024-07-31

3. The Role of Immunomodulatory Therapy with Oxiris in COVID-19 with Renal Failure and Immune Dysfunction;Blood Purification;2024-07-22

4. Preclinical and first-in-human safety studies on a novel magnetism-based haemofiltration method;Scientific Reports;2024-06-18

5. Impact of extracorporeal haemoadsorption during prolonged cardiopulmonary bypass on the incidence of acute kidney injury;The Journal of ExtraCorporeal Technology;2024-06